Please provide your email address to receive an email when new articles are posted on . Kezar Life Sciences has paused a phase 2b trial of zetomipzomib in active lupus nephritis after reporting four ...
In a new study published in Lupus Science & Medicine, researchers reviewed randomized clinical trials (RCTs) to assess therapies for initial management of lupus nephritis (LN), focusing on their ...
Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis ...
BRISBANE, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for ...
FDA placed Kezar’s lupus nephritis drug on clinical hold after four fatal adverse events. Kezar says the autoimmune hepatitis trial remains unaffected. Feel unsure about the market’s next move? Copy ...
Pharmaceutical Technology on MSN
EC approves Roche’s Gazyva to treat active lupus nephritis
Roche has received approval from the European Commission (EC) for its humanised monoclonal antibody Gazyva/Gazyvaro (obinutuzumab) along with mycophenolate mofetil (MMF), for adults with active Class ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing a novel small molecule to treat unmet needs in immune-mediated ...
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced ...
The landscape of lupus nephritis treatment is poised to change in coming years. In keeping with recent successes in treating lupus nephritis, such as the FDA approvals of belimumab and voclosporin, ...
In a post hoc analysis of the phase 2 NOBILITY trial, researchers found that treatment with obinutuzumab—an antibody that targets a protein expressed on certain immune cells—was superior to placebo ...
AJMC ®: What measures can be taken to enhance comprehensive screening efforts for the early diagnosis of lupus nephritis in patients who have systemic lupus erythematosus? How do you screen for lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback